Featured articles from the journal CHEST®, September 2022
Glenview, IL September 20, 2022
Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
The September issue of CHEST journal contains 40 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.
“With September serving as pulmonary fibrosis awareness month, I recommend reading original research such as “Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis,” published in the September issue, which finds that rural participants with idiopathic pulmonary fibrosis present with worse disease severity compared with their suburban counterparts,” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Lung diseases like pulmonary fibrosis and more in the fields of pulmonary, critical care and sleep medicine will be covered extensively at the upcoming CHEST Annual Meeting in Nashville, Oct. 16-19. The journal CHEST will publish all presented abstracts one week before the conference begins, and authors will speak to the research live at the meeting.”
Also included in the current issue of the journal CHEST:
Original research, “Asthma Control, Airway Mucus, and 129Xe MRI Ventilation After a Single Benralizumab Dose,” finds that improved airway function can be measured directly after a first benralizumab dose and that the presence of airway mucus could influence this potential response.
Nationwide study, “Factors Associated With Spontaneous Awakening Trial and Spontaneous Breathing Trial Performance in Adults With Critical Illness,” demonstrates that nonmodifiable (age, admitting ICU diagnosis and BMI) and modifiable (ICU symptoms, physical restraint use, use of a target sedation level, etc.) factors influence spontaneous awakening trial and spontaneous breathing trial performance. A visual abstract for the research can be viewed here.
Caption: What Factors Are Associated With Spontaneous Awakening Trial (SAT) and Spontaneous Breathing Trial (SBT) Performance? (Credit: Michele C. Balas, PhD, RN, CCRN-K, et al. CHEST September 2022 https://doi.org/10.1016/j.chest.2022.01.018).
A state-of-the-art review, “Sex and Gender in Lung Disease and Sleep Disorders,” provides a look into specific effects of sex and gender focused on epidemiology, disease presentation, risk factors and management of lung diseases.
“The Association of Health Care System Resources With Lung Cancer Screening Implementation” indicates that policies that increase system-level resources within the Veterans Health Administration could improve lung cancer screening reach and sustainability. An animation of this research can be viewed here.
Notes for editors
Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at firstname.lastname@example.org.
About the journal CHEST®
The journal CHEST, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org.
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.
Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Laura DiMasi, PR and Communications Specialist
American College of Chest Physicians (CHEST)